Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cencora Inc
(NY:
COR
)
238.11
+1.44 (+0.61%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cencora Inc
Cencora Elects Frank Clyburn to Its Board of Directors
August 15, 2024
From
Cencora
Via
Business Wire
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
August 01, 2024
From
Cencora
Via
Business Wire
Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds
August 01, 2024
From
Walgreens Boots Alliance
Via
Business Wire
Cencora Reports Fiscal 2024 Third Quarter Results
July 31, 2024
From
Cencora
Via
Business Wire
Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
July 05, 2024
From
Cencora
Via
Business Wire
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
May 22, 2024
From
Cencora
Via
Business Wire
Cencora Reports Fiscal 2024 Second Quarter Results
May 01, 2024
From
Cencora
Via
Business Wire
Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
April 05, 2024
From
Cencora
Via
Business Wire
Cencora Announces Leadership Succession Plan
March 12, 2024
From
Cencora
Via
Business Wire
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
February 07, 2024
From
Cencora
Via
Business Wire
Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds
February 07, 2024
From
Walgreens Boots Alliance
Via
Business Wire
Cencora Closes $500 Million Senior Notes Offering
February 07, 2024
From
Cencora
Via
Business Wire
Cencora Prices $500 Million 5.125% Senior Notes Due 2034
February 05, 2024
From
Cencora
Via
Business Wire
Cencora Reports Fiscal 2024 First Quarter Results
January 31, 2024
From
Cencora
Via
Business Wire
Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
January 04, 2024
From
Cencora
Via
Business Wire
Teva Pharma is the way to play the re-rise of generic drugs
November 28, 2023
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth
Via
MarketBeat
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
November 09, 2023
From
Cencora
Via
Business Wire
Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
November 02, 2023
From
Cencora
Via
Business Wire
Eli Lilly, McKesson, Novartis Flash Promising Chart Action
October 09, 2023
Eli Lilly, McKesson, and Novartis are catching investors' attention with promising chart patterns and revenue growth, signaling potential buying opportunities.
Via
MarketBeat
Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release
October 02, 2023
From
Cencora
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.